The Impact of Cirrhosis and History of Hepatocellular Carcinoma on All-Cause Mortality After Eradication of Hepatitis C Virus in Patients With Chronic Hepatitis C-Reference-Cited by-同舟云学术

The Impact of Cirrhosis and History of Hepatocellular Carcinoma on All-Cause Mortality After Eradication of Hepatitis C Virus in Patients With Chronic Hepatitis C

Published:2022 Issue:4 Volume:1 Page:508-515
ISSN:2772-5723
Container-title:Gastro Hep Advances
language:en
Short-container-title:Gastro Hep Advances

Author:

Toyoda Hidenori^ORCID,Atsukawa Masanori,Uojima Haruki,Nozaki Akito,Takaguchi Koichi,Hiraoka Atsushi,Itobayashi Ei,Watanabe Tsunamasa,Matsuura Kentaro,Shimada Noritomo,Abe Hiroshi,Tsuji Kunihiko,Itokawa Norio,Mikami Shigeru,Ishikawa Toru,Oikawa Tsunekazu,Yasuda Satoshi,Chuma Makoto,Tsutsui Akemi,Ikeda Hiroki,Arai Taeang,Tsubota Akihito,Kumada Takashi,Tanaka Yasuhito,Tanaka Junko

Publisher

Elsevier BV

Reference15 articles.

1. Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis;Majumdar;Aliment Pharmacol Ther,2016

2. Trends and efficacy of interferon-free anti-hepatitis C virus therapy in the region of high prevalence of elderly patients, cirrhosis, and hepatocellular carcinoma: a real-world, nationwide, multicenter study of 10688 patients in Japan;Toyoda;Open Forum Infect Dis,2019

3. Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals;Prenner;J Hepatol,2017

4. High efficacy of direct-acting antiviral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma;Persico;Aliment Pharmacol Ther,2018

5. Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: a systematic review and meta-analysis;Ji;J Hepatol,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein kinase C delta enhances the diagnostic performance of hepatocellular carcinoma;Biomarkers;2024-02-15